期刊: CIRCULATION, 2022; 146 (4)
Background: More than one-fifth of the world's population consumes Chinese cuisines regularly, but no evidence-based healthy diets fitting the Chinese......
期刊: CIRCULATION, 2022; 145 (5)
Background: High salt intake is the leading dietary risk factor for cardiovascular diseases. Although clinical evidence suggests that high salt intake......
期刊: CIRCULATION, 2022; 145 (6)
Background: The nuclear receptor Rev-erb alpha/beta, a key component of the circadian clock, emerges as a drug target for heart diseases, but the func......
期刊: CIRCULATION, 2022; 145 (15)
Background: Cardiac ischemia/reperfusion (I/R) injury has emerged as an important therapeutic target for ischemic heart disease, the leading cause of ......
期刊: CIRCULATION, 2022; 145 (25)
BACKGROUND: Catheter ablation as first-line therapy for ventricular tachycardia (VT) at the time of implantable cardioverter defibrillator (ICD) impla......
期刊: CIRCULATION, 2022; 146 (20)
BACKGROUND: Exercise is an effective nonpharmacological strategy to alleviate diabetic cardiomyopathy (DCM) through poorly defined mechanisms. FGF21 (......